Expression of concern
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Paper Information
Record ID:
42848
Author(s):
Publication Date:
December 09, 2019
Retraction Date:
February 23, 2021
(4.8 years years ago)
Subjects:
Institutions:
- Clinical Medical Laboratory, Binzhou Medical University Hospital, Binzhou, 256603, People’s Republic of China
- Cancer research institute, Binzhou Medical University Hospital, Binzhou, 256603, People’s Republic of China
- Department of Thyroid and Breast Surgery, Binzhou Medical University Hospital, Binzhou, 256603, People’s Republic of China
- Department of Pain, Binzhou Medical University Hospital, Binzhou, 256603, People’s Republic of China
- Department of Gastrointestinal Surgery, Binzhou Medical University Hospital, Binzhou, 256603, People’s Republic of China
- Department of Clinical Laboratory, Binzhou Medical University Hospital, Binzhou, 256603, People’s Republic of China
- Department of Hepatobiliary Surgery, Binzhou Medical University Hospital, Binzhou, 256603, People’s Republic of China
- Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, 256603, People’s Republic of China
- Department of Nursing, Binzhou Polytechnic University, Binzhou, 256603, People’s Republic of China
Country:
🇨🇴 ColombiaArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1186/s13045-021-01048-8Citations (410)
410
Total Citations345
Post-Retraction(84.1%)
62
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
7
Within 30 days
112
Within 1 year
117
After 2+ years
1604
Days since retraction (latest)
METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2
Shu Zhao, Peng Song, Gang Zhou et al. (5 authors)
Cancer Gene Therapy
Published: Apr 2023
12 citations
12 citations
793 days after retraction
Post-transcriptional modification of m6A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer
Yang Li, Shimiao Zhu, Yutong Chen et al. (15 authors)
Cell Death and Disease
Open Access
Published: Apr 2023
23 citations
23 citations
790 days after retraction
Novel insights into the multifaceted roles of m6A-modified LncRNAs in cancers: biological functions and therapeutic applications
Jinxin Tang, Jinhui Zhang, Lu Yu et al. (8 authors)
Biomarker Research
Open Access
Published: Apr 2023
15 citations
15 citations
783 days after retraction
Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
Hongyu Shen, Jin Zhang, Di Xu et al. (8 authors)
Medicine
Open Access
Published: Apr 2023
2 citations
2 citations
780 days after retraction
Unravelling Strain-Specific Modifications of Toxoplasma gondii tRNA and sncRNA Using LC-MS/MS
Wei Wang, Yi Yang, Huanping Guo et al. (9 authors)
Microbiology Spectrum
Open Access
Published: Apr 2023
2 citations
2 citations
776 days after retraction
Comprehensive analyses of molecular features, prognostic values, and regulatory functionalities of m6A-modified long non-coding RNAs in lung adenocarcinoma
Yili Ping, Jingjuan Huang, Jichao Zhu et al. (8 authors)
Clinical Epigenetics
Open Access
Published: Apr 2023
3 citations
3 citations
773 days after retraction
Comprehensive review on patulin and Alternaria toxins in fruit and derived products
Syed Asim Shah Bacha, Yinping Li, Jiyun Nie et al. (6 authors)
Frontiers in Plant Science
Open Access
Published: Apr 2023
53 citations
53 citations
769 days after retraction
Exploring m6A‐RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome
Reem Faraj, Ying Liang, Anlin Feng et al. (6 authors)
Pulmonary Circulation
Open Access
Published: Apr 2023
11 citations
11 citations
767 days after retraction
Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy
Nan Xing, Qinyun Du, Sa Guo et al. (8 authors)
Cell Death Discovery
Open Access
Published: Apr 2023
55 citations
55 citations
767 days after retraction
Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds
Abdul Rashid Issahaku, Samukelisiwe Minenhle Mncube, Clement Agoni et al. (12 authors)
Journal of Molecular Modeling
Published: Mar 2023
11 citations
11 citations
765 days after retraction
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy
Mei-Ning Diao, Xiao‐Jing Zhang, Yinfeng Zhang
British Journal of Cancer
Open Access
Published: Mar 2023
22 citations
22 citations
765 days after retraction
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy
Yueqin Sun, Weitao Shen, Shulu Hu et al. (8 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Mar 2023
138 citations
138 citations
752 days after retraction
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu et al. (7 authors)
Frontiers in Immunology
Open Access
Published: Mar 2023
62 citations
62 citations
749 days after retraction
The significance of N6-methyladenosine-modified non-coding RNAs in different disorders
Soudeh Ghafouri‐Fard, Hamed Shoorei, Bashdar Mahmud Hussen et al. (7 authors)
European Journal of Pharmacology
Published: Mar 2023
3 citations
3 citations
749 days after retraction
RNA N6-methyladenosine modification in female reproductive biology and pathophysiology
Erqing Huang, Lijuan Chen
Cell Communication and Signaling
Open Access
Published: Mar 2023
26 citations
26 citations
744 days after retraction
HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
Ke Li, Quan Gong, Xudong Xiang et al. (13 authors)
Research Square (Research Square)
Open Access
Published: Mar 2023
736 days after retraction
N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells
Chuhan Wang, Danli ma, Huimin Yu et al. (5 authors)
Heliyon
Open Access
Published: Feb 2023
15 citations
15 citations
733 days after retraction
The Suppression Effects of Fat Mass and Obesity Associated Gene on the Hair Follicle-Derived Neural Crest Stem Cells Differentiating into Melanocyte by N6-Methyladenosine Modifying Microphthalmia-Associated Transcription Factor
Zhiwei Shang, Haixia Feng, Liye Xia
International Journal of Stem Cells
Open Access
Published: Feb 2023
3 citations
3 citations
731 days after retraction
N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2
Haibo Xia, Yan Wu, Jing Zhao et al. (10 authors)
Cell Death and Differentiation
Published: Feb 2023
89 citations
89 citations
731 days after retraction
Retraction Note: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Dan Jin, Jiwei Guo, Yan Wu et al. (12 authors)
Journal of Hematology & Oncology
Open Access
Published: Feb 2023
4 citations
4 citations
729 days after retraction
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences
Open Access
Published: Feb 2023
12 citations
12 citations
727 days after retraction
Ezrin regulates the progression of NSCLC by YAP and PD-L1
Fan Bu, Yeping Zhang, Ning Zhao et al. (5 authors)
Clinical & Translational Oncology
Published: Feb 2023
723 days after retraction
The m6A methyltransferase METTL3 affects cell proliferation and migration by regulating YAP expression in Hirschsprung disease
Zhaorong Huang, Luo Caiyun, Xinwei Hou et al. (10 authors)
Pediatric Surgery International
Published: Feb 2023
8 citations
8 citations
722 days after retraction
Epigenetic reprogramming in cancer: From diagnosis to treatment
Pedro M. S. Costa, Sarah Leyenne Alves Sales, Daniel Pascoalino Pinheiro et al. (8 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Feb 2023
40 citations
40 citations
721 days after retraction
METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2—breast cancer
Dengjie Ouyang, Tao Hong, Mengdie Fu et al. (12 authors)
Breast Cancer Research
Open Access
Published: Feb 2023
16 citations
16 citations
717 days after retraction
Human Keratinocyte-Derived Exosomal MALAT1 Promotes Diabetic Wound Healing by Upregulating MFGE8 via microRNA-1914-3p
Liwen Kuang, Chenchen Zhang, Binghui Li et al. (6 authors)
International Journal of Nanomedicine
Open Access
Published: Feb 2023
29 citations
29 citations
708 days after retraction
Critical Roles of METTL3 in Translation Regulation of Cancer
Wangyang Meng, Xiao Han, Peiyuan Mei et al. (7 authors)
Biomolecules
Open Access
Published: Jan 2023
11 citations
11 citations
703 days after retraction
RNA methylation and cellular response to oxidative stress-promoting anticancer agents
Marco Ponzetti, Nadia Rucci, Stefano Falone
Cell Cycle
Open Access
Published: Jan 2023
15 citations
15 citations
693 days after retraction
The function and clinical implication of YTHDF1 in the human system development and cancer
Wenjun Ren, Yixiao Yuan, Yongwu Li et al. (6 authors)
Biomarker Research
Open Access
Published: Jan 2023
29 citations
29 citations
693 days after retraction
ABRO1 arrests cardiomyocyte proliferation and myocardial repair by suppressing PSPH
Tao Wang, Lu‐Yu Zhou, Xinmin Li et al. (12 authors)
Molecular Therapy
Open Access
Published: Jan 2023
16 citations
16 citations
689 days after retraction
NPTX2 Promotes Epithelial–Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma through METTL3-Mediated N6-Methyladenosine Methylation of SNAIL
Tong Kang, Cheng Zhang, Hao Lei et al. (10 authors)
Journal of Investigative Dermatology
Published: Jan 2023
4 citations
4 citations
686 days after retraction
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase
Hao Huang, Guangyuan Zhao, Horacio Cárdenas et al. (6 authors)
Molecular Cancer Therapeutics
Open Access
Published: Jan 2023
14 citations
14 citations
685 days after retraction
METTL3 promotes hyperoxia-induced pyroptosis in neonatal bronchopulmonary dysplasia by inhibiting ATG8-mediated autophagy
Lili Xu, Zhan Shi, Zhaojun Pan et al. (4 authors)
Clinics
Open Access
Published: Jan 2023
5 citations
5 citations
677 days after retraction
Development and validation of a N6 methylation regulator-related gene signature for prognostic and immune response prediction in non-small cell lung cancer.
Xiang Li, Jinlong Ma, Zhenqian Sun et al. (7 authors)
PubMed
Published: Jan 2023
3 citations
3 citations
677 days after retraction
Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment
Dan Wang, Yingying Han, Lushan Peng et al. (7 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2023
27 citations
27 citations
677 days after retraction
METTL3-mediated m<sup>6</sup>A modification of lncRNA SNHG3 accelerates gastric cancer progression by modulating miR-186-5p/cyclinD2 axis
Guo Ji, Xiu Wang, Hao Xi
International Journal of Immunopathology and Pharmacology
Open Access
Published: Jan 2023
5 citations
5 citations
677 days after retraction
Novel Insights into The Roles of N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) Modification and Autophagy in Human Diseases
Jiaxin Liang, Jingwen Sun, Wei Zhang et al. (10 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2023
15 citations
15 citations
677 days after retraction
Structural dynamics of eukaryotic H/ACA RNPs from saccharomyces cerevisiae & structural dynamics of the Guanidine-II riboswitch from escherichia coli
Christin Fuks
Unknown Journal
Open Access
Published: Jan 2023
677 days after retraction
Novel insights into the interplay between m6A modification and programmed cell death in cancer
Jinhao Chen, Mujie Ye, Jian’an Bai et al. (8 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2023
17 citations
17 citations
677 days after retraction
METTL3 Promotes the Growth and Invasion of Melanoma Cells by Regulating the lncRNA SNHG3/miR-330-5p Axis
Shaojun Chu, Yulong Li, Baojin Wu et al. (8 authors)
Cell Transplantation
Open Access
Published: Jan 2023
12 citations
12 citations
677 days after retraction
Methyltransferase‐like 3 suppresses phenotypic switching of vascular smooth muscle cells by activating autophagosome formation
Zemin Fang, Shumin Zhang, Hanshen Luo et al. (13 authors)
Cell Proliferation
Open Access
Published: Dec 2022
30 citations
30 citations
668 days after retraction
Increased levels of N6-methyladenosine in peripheral blood RNA: a perspective diagnostic biomarker and therapeutic target for non-small cell lung cancer
Haofan Yin, Honghai Hong, Ping Yin et al. (9 authors)
Clinical Chemistry and Laboratory Medicine (CCLM)
Published: Dec 2022
7 citations
7 citations
666 days after retraction
HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells
Zhuoyu Gu, Yang Yang, Qian Ma et al. (7 authors)
Respiratory Research
Open Access
Published: Dec 2022
22 citations
22 citations
664 days after retraction
Amentoflavone and methyl hesperidin, novel lead molecules targeting epitranscriptomic modulator in acute myeloid leukemia: in silico drug screening and molecular dynamics simulation approach
Shibambika Manna, Pragati Samal, Rohini Basak et al. (9 authors)
Journal of Molecular Modeling
Open Access
Published: Dec 2022
18 citations
18 citations
661 days after retraction
RNA Epigenetics in Chronic Lung Diseases
Xiaorui Wang, Zhihou Guo, Furong Yan
Genes
Open Access
Published: Dec 2022
6 citations
6 citations
661 days after retraction
Biological and pharmacological roles of m6A modifications in cancer drug resistance
Zaoqu Liu, Haijiao Zou, Qin Dang et al. (10 authors)
Molecular Cancer
Open Access
Published: Dec 2022
65 citations
65 citations
659 days after retraction
<scp>N6</scp>‐methyladenosine promotes osteogenic differentiation of <scp>PDLSCs</scp> from periodontitis patients
Xiaochen Zhang, Jia Liu, Jie Gao et al. (8 authors)
Oral Diseases
Published: Dec 2022
12 citations
12 citations
659 days after retraction
The m 6 A methyltransferase METTL3 affects cell proliferation and migration by regulating YAP expression in Hirschsprung disease
Zhaorong Huang, Luo Caiyun, Xinwei Hou et al. (10 authors)
Research Square (Research Square)
Published: Dec 2022
650 days after retraction
M2-TAMs promote immunoresistance in lung adenocarcinoma by enhancing METTL3-mediated m6A methylation
Lige Wu, Daoan Cheng, Xin Yang et al. (7 authors)
Annals of Translational Medicine
Open Access
Published: Dec 2022
13 citations
13 citations
646 days after retraction
<scp>RNA m6A</scp> methyltransferase <scp>METTL14</scp> promotes the procession of non‐small cell lung cancer by targeted <scp>CSF1R</scp>
Siying Ren, Ying Xiao, Lulu Yang et al. (4 authors)
Thoracic Cancer
Open Access
Published: Nov 2022
11 citations
11 citations
644 days after retraction
Related Records
This article has multiple records in the database due to different notices:
Record #42846
Feb 22, 2023Record #42847
Aug 03, 2020Quick Stats
Total Citations:
410
Years Since Retraction:
4.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025